Ana Pocivavsek - Publications

Affiliations: 
Georgetown University, Washington, DC 
 Duke University, Durham, NC 
 University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
schizophrenia, cognition

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Glassman M, Wehring HJ, Pocivavsek A, Sullivan KM, Rowland LM, McMahon RP, Chiappelli J, Liu F, Kelly DL. Peripheral Cortisol and Inflammatory Response to a Psychosocial Stressor in People with Schizophrenia. Journal of Neuropsychiatry (Foster City, Calif.). 2. PMID 30801048 DOI: 10.21767/2471-8548.10008  0.44
2018 Pocivavsek A, Elmer GI, Schwarcz R. Inhibition of Kynurenine Aminotransferase II Attenuates Hippocampus-dependent Memory Deficit in Adult Rats Treated Prenatally with Kynurenine. Hippocampus. PMID 30311334 DOI: 10.1002/hipo.23040  0.8
2018 Notarangelo FM, Pocivavsek A, Schwarcz R. Exercise Your Kynurenines to Fight Depression. Trends in Neurosciences. 41: 491-493. PMID 30053952 DOI: 10.1016/j.tins.2018.05.010  0.88
2018 Chiappelli J, Rowland LM, Notarangelo FM, Wijtenburg SA, Thomas MAR, Pocivavsek A, Jones A, Wisner K, Kochunov P, Schwarcz R, Hong LE. Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29728648 DOI: 10.1038/s41386-018-0072-2  0.88
2018 Chiappelli J, Notarangelo FM, Pocivavsek A, Thomas MAR, Rowland LM, Schwarcz R, Hong LE. Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29520060 DOI: 10.1038/s41386-018-0038-4  0.88
2017 Pocivavsek A, Rowland LM. Basic Neuroscience Illuminates Causal Relationship between Sleep and Memory: Translating to Schizophrenia. Schizophrenia Bulletin. PMID 29136236 DOI: 10.1093/schbul/sbx151  0.44
2017 Hahn B, Reneski CH, Pocivavsek A, Schwarcz R. Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood. Psychopharmacology. PMID 29128872 DOI: 10.1007/s00213-017-4780-9  0.8
2017 Goeden N, Notarangelo FM, Pocivavsek A, Beggiato S, Bonnin A, Schwarcz R. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid. Developmental Neuroscience. PMID 29080891 DOI: 10.1159/000481168  0.88
2016 Erhardt S, Pocivavsek A, Repici M, Liu XC, Imbeault S, Maddison DC, Thomas MA, Smalley JL, Larsson MK, Muchowski PJ, Giorgini F, Schwarcz R. Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders. Biological Psychiatry. PMID 28187857 DOI: 10.1016/j.biopsych.2016.12.011  0.8
2016 Pershing ML, Phenis D, Valentini V, Pocivavsek A, Lindquist DH, Schwarcz R, Bruno JP. Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding. Psychopharmacology. PMID 27527585 DOI: 10.1007/s00213-016-4404-9  0.8
2016 Clark SM, Pocivavsek A, Nicholson JD, Notarangelo FM, Langenberg P, McMahon RP, Kleinman JE, Hyde TM, Stiller J, Postolache TT, Schwarcz R, Tonelli LH. Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals. Journal of Psychiatry & Neuroscience : Jpn. 41: 150226. PMID 27070351 DOI: 10.1503/jpn.150226  0.88
2016 Notarangelo FM, Pocivavsek A. Elevated Kynurenine Pathway Metabolism during Neurodevelopment: Implications for Brain and Behavior. Neuropharmacology. PMID 26944732 DOI: 10.1016/j.neuropharm.2016.03.001  0.88
2015 Pershing ML, Bortz DM, Pocivavsek A, Fredericks PJ, Jørgensen CV, Vunck SA, Leuner B, Schwarcz R, Bruno JP. Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia. Neuropharmacology. 90: 33-41. PMID 25446576 DOI: 10.1016/j.neuropharm.2014.10.017  0.56
2015 Campbell BM, Pocivavsek A, Notarangelo FM, Parachikova AI. Chapter 19: The role of kynurenine pathway metabolites in neuropsychiatric disorders Targeting the Broadly Pathogenic Kynurenine Pathway. 241-254. DOI: 10.1007/978-3-319-11870-3_19  0.56
2014 Chiappelli J, Pocivavsek A, Nugent KL, Notarangelo FM, Kochunov P, Rowland LM, Schwarcz R, Hong LE. Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance. Jama Psychiatry. 71: 761-8. PMID 24806441 DOI: 10.1001/jamapsychiatry.2014.243  0.56
2014 Pocivavsek A, Thomas MA, Elmer GI, Bruno JP, Schwarcz R. Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats. Psychopharmacology. 231: 2799-809. PMID 24590052 DOI: 10.1007/s00213-014-3452-2  0.56
2014 Wu HQ, Okuyama M, Kajii Y, Pocivavsek A, Bruno JP, Schwarcz R. Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor. Schizophrenia Bulletin. 40: S152-8. PMID 24562494 DOI: 10.1093/schbul/sbt157  0.56
2013 Alexander KS, Pocivavsek A, Wu HQ, Pershing ML, Schwarcz R, Bruno JP. Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine. Neuroscience. 238: 19-28. PMID 23395862 DOI: 10.1016/j.neuroscience.2013.01.063  0.56
2012 Pocivavsek A, Wu HQ, Elmer GI, Bruno JP, Schwarcz R. Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood. The European Journal of Neuroscience. 35: 1605-12. PMID 22515201 DOI: 10.1111/j.1460-9568.2012.08064.x  0.56
2011 Pocivavsek A, Wu HQ, Potter MC, Elmer GI, Pellicciari R, Schwarcz R. Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2357-67. PMID 21796108 DOI: 10.1038/npp.2011.127  0.56
2011 Loane DJ, Washington PM, Vardanian L, Pocivavsek A, Hoe HS, Duff KE, Cernak I, Rebeck GW, Faden AI, Burns MP. Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury. Journal of Neurotrauma. 28: 225-36. PMID 21175399 DOI: 10.1089/neu.2010.1595  0.8
2009 Pocivavsek A, Rebeck GW. Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo. Biochemical and Biophysical Research Communications. 387: 516-20. PMID 19615334 DOI: 10.1016/j.bbrc.2009.07.048  0.8
2009 Pocivavsek A, Mikhailenko I, Strickland DK, Rebeck GW. Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation. Journal of Neuroimmunology. 214: 25-32. PMID 19586665 DOI: 10.1016/j.jneuroim.2009.06.010  0.8
2009 Liu Y, Pocivavsek A, Papadopoulos V. Dehydroepiandrosterone formation is independent of cytochrome P450 17alpha-hydroxylase/17, 20 lyase activity in the mouse brain. The Journal of Steroid Biochemistry and Molecular Biology. 115: 86-90. PMID 19500726 DOI: 10.1016/j.jsbmb.2009.03.005  0.8
2009 Loane DJ, Pocivavsek A, Moussa CE, Thompson R, Matsuoka Y, Faden AI, Rebeck GW, Burns MP. Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nature Medicine. 15: 377-9. PMID 19287391 DOI: 10.1038/nm.1940  0.8
2009 Pocivavsek A, Burns MP, Rebeck GW. Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase. Glia. 57: 444-53. PMID 18803301 DOI: 10.1002/glia.20772  0.8
2006 Hoe HS, Pocivavsek A, Dai H, Chakraborty G, Harris DC, Rebeck GW. Effects of apoE on neuronal signaling and APP processing in rodent brain. Brain Research. 1112: 70-9. PMID 16905123 DOI: 10.1016/j.brainres.2006.07.035  0.8
2006 Pocivavsek A, Icenogle L, Levin ED. Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats. Psychopharmacology. 188: 597-604. PMID 16715255 DOI: 10.1007/s00213-006-0416-1  0.56
2006 Hoe HS, Pocivavsek A, Chakraborty G, Fu Z, Vicini S, Ehlers MD, Rebeck GW. Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor. The Journal of Biological Chemistry. 281: 3425-31. PMID 16332682 DOI: 10.1074/jbc.M509380200  0.8
2005 Addy NA, Pocivavsek A, Levin ED. Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1121-7. PMID 15688087 DOI: 10.1038/sj.npp.1300669  0.56
Show low-probability matches.